Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

T lymphocyte phenotype of contact-allergic patients: experience with nickel and p-phenylenediamine.

Wicks K, Stretton C, Popple A, Beresford L, Williams J, Maxwell G, Gosling JP, Kimber I, Dearman RJ.

Contact Dermatitis. 2019 Jul;81(1):43-53. doi: 10.1111/cod.13246. Epub 2019 Apr 8.

2.

Chronic Inflammation in Response to Injury: Retention of Myeloid Cells in Injured Tissue Is Driven by Myeloid Cell Intrinsic Factors.

Torbica T, Wicks K, Umehara T, Gungordu L, Alrdahe S, Wemyss K, Grainger JR, Mace KA.

J Invest Dermatol. 2019 Jul;139(7):1583-1592. doi: 10.1016/j.jid.2018.12.030. Epub 2019 Jan 28.

PMID:
30703358
3.

Mobile produce market influences access to fruits and vegetables in an urban environment.

Hsiao BS, Sibeko L, Wicks K, Troy LM.

Public Health Nutr. 2018 May;21(7):1332-1344. doi: 10.1017/S1368980017003755. Epub 2018 Jan 10.

PMID:
29317002
4.

Direct Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis.

Vara D, Watt JM, Fortunato TM, Mellor H, Burgess M, Wicks K, Mace K, Reeksting S, Lubben A, Wheeler-Jones CPD, Pula G.

Antioxid Redox Signal. 2018 Jan 10;28(2):110-130. doi: 10.1089/ars.2016.6869. Epub 2017 Sep 18.

5.

Diabetes Inhibits Gr-1+ Myeloid Cell Maturation via Cebpa Deregulation.

Wicks K, Torbica T, Umehara T, Amin S, Bobola N, Mace KA.

Diabetes. 2015 Dec;64(12):4184-97. doi: 10.2337/db14-1895. Epub 2015 Aug 31.

6.

Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound.

Wicks K, Torbica T, Mace KA.

Semin Immunol. 2014 Aug;26(4):341-53. doi: 10.1016/j.smim.2014.04.006. Epub 2014 Jun 18. Review.

PMID:
24954378
7.

Functional differences exist between TNFα promoters encoding the common -237G SNP and the rarer HLA-B*5701-linked A variant.

Simpson PD, Moysi E, Wicks K, Sudan K, Rowland-Jones SL, McMichael AJ, Knight J, Gillespie GM.

PLoS One. 2012;7(7):e40100. doi: 10.1371/journal.pone.0040100. Epub 2012 Jul 13.

8.

RNAi2011: Gene Regulation by Small RNAs.

Wicks K, Carter DR.

J RNAi Gene Silencing. 2011;7:431-3. Epub 2011 Jun 1. No abstract available.

9.

Pseudogenes: pseudo-functional or key regulators in health and disease?

Pink RC, Wicks K, Caley DP, Punch EK, Jacobs L, Carter DR.

RNA. 2011 May;17(5):792-8. doi: 10.1261/rna.2658311. Epub 2011 Mar 11. Review.

10.

Transcriptional repression and DNA looping associated with a novel regulatory element in the final exon of the lymphotoxin-β gene.

Wicks K, Knight JC.

Genes Immun. 2011 Mar;12(2):126-35. doi: 10.1038/gene.2010.62. Epub 2011 Jan 20.

11.

Use of an automated clinical management system improves outpatient immunosuppressive care following liver transplantation.

Park ES, Peccoud MR, Wicks KA, Halldorson JB, Carithers RL Jr, Reyes JD, Perkins JD.

J Am Med Inform Assoc. 2010 Jul-Aug;17(4):396-402. doi: 10.1136/jamia.2009.000992.

12.

Scaffold proteins IRSp53 and spinophilin regulate localized Rac activation by T-lymphocyte invasion and metastasis protein 1 (TIAM1).

Rajagopal S, Ji Y, Xu K, Li Y, Wicks K, Liu J, Wong KW, Herman IM, Isberg RR, Buchsbaum RJ.

J Biol Chem. 2010 Jun 4;285(23):18060-71. doi: 10.1074/jbc.M109.051490. Epub 2010 Apr 1.

13.

Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.

Gasperíková D, Tribble ND, Staník J, Hucková M, Misovicová N, van de Bunt M, Valentínová L, Barrow BA, Barák L, Dobránsky R, Bereczková E, Michálek J, Wicks K, Colclough K, Knight JC, Ellard S, Klimes I, Gloyn AL.

Diabetes. 2009 Aug;58(8):1929-35. doi: 10.2337/db09-0070. Epub 2009 May 1.

14.

The use of FT-IR as a screening technique for organic residue analysis of archaeological samples.

Shillito LM, Almond MJ, Wicks K, Marshall LJ, Matthews W.

Spectrochim Acta A Mol Biomol Spectrosc. 2009 Feb;72(1):120-5. doi: 10.1016/j.saa.2008.08.016. Epub 2008 Sep 17.

PMID:
18952494
15.

Chromatin profiling across the human tumour necrosis factor gene locus reveals a complex, cell type-specific landscape with novel regulatory elements.

Taylor JM, Wicks K, Vandiedonck C, Knight JC.

Nucleic Acids Res. 2008 Sep;36(15):4845-62. doi: 10.1093/nar/gkn444. Epub 2008 Jul 24.

16.

Effect of denervation on mitochondrially mediated apoptosis in skeletal muscle.

Adhihetty PJ, O'Leary MF, Chabi B, Wicks KL, Hood DA.

J Appl Physiol (1985). 2007 Mar;102(3):1143-51. Epub 2006 Nov 22.

17.

Allelic variation in the CNDP1 gene and its lack of association with longevity and coronary heart disease.

Zschocke J, Nebel A, Wicks K, Peters V, El Mokhtari NE, Krawczak M, van der Woude F, Janssen B, Schreiber S.

Mech Ageing Dev. 2006 Nov;127(11):817-20. Epub 2006 Sep 11.

PMID:
16965804
18.
19.

Formula for surgical practice resuscitation in an academic medical center.

Sinanan M, Wicks K, Peccoud M, Canfield J, Poser L, Sailer L, Stephens K, Edwards D.

Am J Surg. 2000 May;179(5):417-21.

PMID:
10930493
20.

Equitable service provision for inclusive education and effective early intervention.

Wicks KM.

Int J Lang Commun Disord. 1998;33 Suppl:562-7.

PMID:
10343755
21.

Histopathology of breast cancer in relation to age.

Fisher CJ, Egan MK, Smith P, Wicks K, Millis RR, Fentiman IS.

Br J Cancer. 1997;75(4):593-6.

22.

KiS1--a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma.

Sampson SA, Kreipe H, Gillett CE, Smith P, Chaudary MA, Khan A, Wicks K, Parwaresch R, Barnes DM.

J Pathol. 1992 Oct;168(2):179-85. Erratum in: J Pathol 1993 Feb;169(2):287.

PMID:
1460535
23.

Mitochondrial adaptations in denervated muscle: relationship to muscle performance.

Wicks KL, Hood DA.

Am J Physiol. 1991 Apr;260(4 Pt 1):C841-50.

PMID:
1850197
24.

A team approach to the child with a craniofacial defect.

Anderson BE, Wicks K.

Plast Surg Nurs. 1985 Spring;5(1):32-6. No abstract available.

PMID:
3847076
25.

Mathematical and clinical investigation of the RP6-rhodial 75 system. Evaluation of high and low middle molecular clearance dialysis.

Jørstad S, Widerøe TE, Smedby L, Berg KJ, Wicks K.

Scand J Urol Nephrol. 1978;12(2):167-74.

PMID:
694443

Supplemental Content

Support Center